Disclosure Status of Pharmaceutical Sector Data. Part of Component 1 of the MeTA Baseline Assessments. Zambia, June 2010
(2010; 36 pages)


Zambia like other MeTA pilot countries is developing strategies to promote greater transparency and accountability regarding policies, practices, and outcomes in the pharmaceutical sector. A survey looking at four areas; Medicines registration and quality assurance; Availability of medicines; Price of medicines, Policies and practices concerning the promotion of medicines, was conducted. Data was collected using a disclosure tool.

For each core area, disclosed information should cover policies – the laws and regulations that are in place; practices – suggested procedures to follow and actual practices; and results – achievements in the core area. The objectives of describing the current disclosure status of information in the core areas are to:

  1. enable the Zambia MeTA Council to prioritize potential activities to facilitate progressive disclosure over time; and
  2. create a baseline against which changes in transparency and disclosure during pilot implementation can be measured.
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017